Hence, the RTK-associated cell signaling, such as the Ras/MAPK and PI3K/Akt pathways, is thought to be down-regulated in cancer cells by EGCG, leading to the modulation of the target gene expression, which is associated with the induction of apoptosis and cell cycle arrest. This evidence concerns the gene AKT1 and cancer.